top of page
Feromics Full Colour Logo_3.8.26.png
Blue Macro eye close up.jpg

REVOLUTIONARY
immune-profiling technology. 

TRANSFORMATIONAL SOLUTIONS THROUGH PRECISION IMMUNOTHERAPY

At Feromics, our mission-focused team of scientists, engineers, and clinicians is dedicated to transforming immunotherapy and delivering groundbreaking therapies. Our solutions include novel drug candidates, proprietary single-cell technologies, and collaborative research initiatives — all designed to drive innovation and deliver actionable assets.

Solutions

DATA DRIVEN, ASSET FOCUSED.

IMMUNOTHERAPY

  • Uncover molecular pathways driving immune cell cytotoxicity and function to advance CAR-T and CAR-Treg therapies..

  • Applications:

— Develop and optimize CAR-T constructs to enhance efficacy and persistence.

— Develop and optimize CAR-Treg constructs to modulate immune responses in autoimmune diseases.

PRECISION MEDICINE

  • Derisk preclinical and clinical development: optimize efficacy and patient outcomes through personalized immune profiling.

  • Donor selection: choose high-efficacy donors for allogeneic immunotherapies.

  • Personalized immunotherapy: select treatments based on individual patient immune profiles.

R & D

REVOLUTIONARY

While most platforms attempt to decipher omics data from functionally heterogeneous immune cells — using AI to find signals in a noisy mixture — Feromics takes a different approach. Our biotechnology and workflow accurately identify, isolate, and analyze immune cell phenotypes specific to a disease, producing high-confidence, actionable data that powers AI models and informs the design of novel immunotherapies.

  • Oncology

  • Immunology

Platform

INNOVATIVE TECHNOLOGY & WORKFLOW

Feromics’ Intelligent Design™ platform uses a bottom-up, engineering-driven workflow to identify, isolate, and analyze unique immune cell phenotypes associated with disease. These single-cell functional datasets power our AI-driven bioinformatics and unlock functional immunomics, decoding immune cell heterogeneity with unprecedented precision. Supported by our team of scientists, engineers, and clinicians, Feromics delivers an asset-focused drug discovery and development platform that accelerates innovation and generates actionable results in immunotherapy and precision medicine.

Strategy

LEADING THE WAY IN PRECISION IMMUNOTHERAPY

Our strategy drives innovation through actionable data and informed decision-making, enabling proven results in cancer and autoimmune disease treatments. Science, collaboration, and patient-centric care are at the core of everything we do.

Screenshot 2025-01-14 at 9.12.39 AM.png

PIPELINE

Feromics is actively applying the Intelligent Design™ platform to develop new therapies. Each discovery is powered by AI models trained on high-quality, functional immunomics data, enabling faster translation into validated targets and actionable therapeutic candidates.

PROGRAM

PRECLINICAL

PHASE 1

PHASE 2

PHASE 3

Diffuse large B-cell lymphoma (DLBCL)

F01-50 ID-CAR-T

Undisclosed indication

F03-50 ID-CAR-T

bottom of page